title: Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator.
abstract: BACKGROUND
  A significant reduction in parasite clearance rates following artesunate treatment of falciparum malaria, and increased failure rates following artemisinin combination treatments (ACT), signaled emergent artemisinin resistance in Western Cambodia. Accurate measurement of parasite clearance is therefore essential to assess the spread of artemisinin resistance in Plasmodium falciparum. The slope of the log-parasitaemia versus time relationship is considered to be the most robust measure of anti-malarial effect. However, an initial lag phase of numerical instability often precedes a steady exponential decline in the parasite count after the start of anti-malarial treatment. This lag complicates the clearance estimation, introduces observer subjectivity, and may influence the accuracy and consistency of reported results.
  
  
  METHODS
  To address this problem, a new approach to modelling clearance of malaria parasites from parasitaemia-time profiles has been explored and validated. The methodology detects when a lag phase is present, selects the most appropriate model (linear, quadratic or cubic) to fit log-transformed parasite data, and calculates estimates of parasite clearance adjusted for this lag phase. Departing from previous approaches, parasite counts below the level of detection are accounted for and not excluded from the calculation.
  
  
  RESULTS
  Data from large clinical studies with frequent parasite counts were examined. The effect of a lag phase on parasite clearance rate estimates is discussed, using individual patient data examples. As part of the World Wide Antimalarial Resistance Network's (WWARN) efforts to make innovative approaches available to the malaria community, an automated informatics tool: the parasite clearance estimator has been developed.
  
  
  CONCLUSIONS
  The parasite clearance estimator provides a consistent, reliable and accurate method to estimate the lag phase and malaria parasite clearance rate. It could be used to detect early signs of emerging resistance to artemisinin derivatives and other compounds which affect ring-stage clearance.
authors.affiliation: WorldWide Anti-malarial Resistance Network (WWARN) and Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Old Road, Oxford, OX3 7LJ, UK.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Flegg
authors.forename: Philippe J
authors.initials: PJ
authors.lastname: Guerin
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: White
authors.forename: Kasia
authors.initials: K
authors.lastname: Stepniewska
mesh_terms: D000962:Antimalarials / Q000008:administration & dosage*; D037621:Artemisinins / Q000008:administration & dosage; D000077332:Artesunate; D001769:Blood / Q000469:parasitology*; D002160:Cambodia; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000469:parasitology*; D059208:Parasite Load / Q000379:methods* / Q000592:standards*; D018512:Parasitemia / Q000469:parasitology; D010963:Plasmodium falciparum / Q000302:isolation & purification*
chemical_list: D000962:Antimalarials; D037621:Artemisinins; D000077332:Artesunate
references.citation: Malar J. 2009 Nov 11;8:253
references.pmid: 19906307
references.citation: Malar J. 2011 Sep 22;10:278
references.pmid: 21939506
references.citation: Malar J. 2009 Feb 23;8:32
references.pmid: 19236701
references.citation: PLoS One. 2009;4(2):e4551
references.pmid: 19234601
references.citation: Antimicrob Agents Chemother. 2010 Jul;54(7):2886-92
references.pmid: 20421395
references.citation: N Engl J Med. 2009 Jul 30;361(5):455-67
references.pmid: 19641202
references.citation: Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):590-7
references.pmid: 1287908
references.citation: Blood. 1996 Dec 15;88(12):4694-700
references.pmid: 8977263
references.citation: Malar J. 2009 Jan 12;8:10
references.pmid: 19138388
references.citation: J Infect Dis. 2010 Feb 15;201(4):570-9
references.pmid: 20085495
references.citation: Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):436-43
references.pmid: 8249075
references.citation: N Engl J Med. 2008 Dec 11;359(24):2619-20
references.pmid: 19064625
references.citation: Lancet Infect Dis. 2002 Sep;2(9):564-73
references.pmid: 12206972
references.citation: J Infect Dis. 2000 Aug;182(2):629-33
references.pmid: 10915102
references.citation: Antimicrob Agents Chemother. 2000 Dec;44(12):3414-24
references.pmid: 11083649
references.citation: Clin Infect Dis. 2010 Dec 1;51(11):e82-9
references.pmid: 21028985
references.citation: Antimicrob Agents Chemother. 1997 Jul;41(7):1413-22
references.pmid: 9210658